Diabetes, Endocrine and Metabolic Disease

糖尿病、内分泌及代谢疾病

• 批准号: 9524708
• 负责人: ANNE R CAPPOLA
• 金额: $ 27.29万
• 依托单位: UNIVERSITY OF PENNSYLVANIA
• 依托单位国家: 美国
• 财政年份: 1978
• 资助国家: 美国
• 起止时间: 1978-09-15 至 2021-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/9524708
• 关键词: Diabetes Mellitus; Endocrine System Diseases; Metabolic Diseases

 DESCRIPTION (provided by applicant): This is a competitive renewal for our longstanding Training Program in Diabetes, Endocrinology, and Metabolic Diseases. During the most recent funding cycle, 4 postdoctoral fellows were supported each year, with an additional postdoctoral fellow supported through a Minority Supplement. A total of 13 trainees working with 10 different mentors were supported during this cycle. The program is designed to accommodate PhD scientists, as well as physician scientists with MD or MD/PhD degrees, of whom most enter through the Penn Clinical Fellowship Program in Endocrinology, Diabetes, and Metabolism. Of the postdoctoral trainees supported by this T32 during the last 4 years who are no longer in training, three have junior faculty positions at Penn (two with current competing offers from outside academic institutions), one is a Senior Scientist at Cellular Dynamics International, and one is an Associate Director of Clinical Research at Teva Pharmaceuticals. For the next period, we request continued funding of four postdoctoral fellows. We also request continued support of Penn's NIDDK Medical Student Research Program, which has supported 22 medical students during this funding cycle. Our 19 training faculty have primary appointments in nine Medical School Departments and one Department in the School of Veterinary Medicine and consist of 12 professors, 5 associate professors, and 2 assistant professors. Seven members of the training faculty are women and one is an underrepresented minority. In the last funding cycle, five mentors left Penn or changed status to emeritus, seven were removed, and seven were appointed to the training grant. Training grant faculty direct programs in β-cell development and function, obesity, hormone action, physiology, diabetic complications, and genetics in humans and model organisms, with expertise in laboratory-based, translational, patient-oriented, and community-based research. This training program continues to provide superb preparation for scientists committed to careers in research into diabetes, endocrinology, and metabolism.

 描述（由申请人提供）：这是对我们长期的糖尿病、内分泌学和代谢疾病培训计划的竞争性更新。在最近的资助周期中，每年有 4 名博士后研究员获得支持，另外还有一名博士后研究员通过少数族裔补充计划获得支持。在此周期中，共有 13 名学员与 10 位不同的导师一起工作获得了支持。该项目旨在容纳博士科学家以及拥有医学博士或医学博士/博士学位的医学科学家，其中大多数是通过宾夕法尼亚大学内分泌学、糖尿病和代谢学临床奖学金项目进入的。在过去 4 年中受 T32 支持且不再接受培训的博士后实习生中，三名在宾夕法尼亚大学担任初级教员（其中两名目前有来自外部学术机构的竞争性职位），一名是 Cellular Dynamics International 的高级科学家，一名是 Teva Pharmaceuticals 的临床研究副总监。在下一阶段，我们请求继续资助四名博士后研究员。我们还请求继续支持宾夕法尼亚大学的 NIDDK 医学生研究计划，该计划在本资助周期内为 22 名医学生提供了支持。我们的 19 名培训教师主要任职于医学院的 9 个系和兽医学院的 1 个系，其中包括 12 名教授、5 名副教授和 2 名助理教授。培训教师中有七名是女性，其中一名是代表性不足的少数族裔。在上一个资助周期中，五名导师离开宾夕法尼亚大学或改为荣休，七名导师被免职，七名导师被任命接受培训补助金。培训资助教师直接开展β细胞发育和功能、肥胖、激素作用、生理学、糖尿病并发症以及人类和模型生物遗传学方面的项目，并在基于实验室、转化、以患者为导向和基于社区的研究方面拥有专业知识。该培训计划继续为致力于糖尿病、内分泌学和新陈代谢研究的科学家提供极好的准备。